A detailed history of Mcintyre Freedman & Flynn Investment Advisers Inc transactions in Amgen Inc stock. As of the latest transaction made, Mcintyre Freedman & Flynn Investment Advisers Inc holds 842 shares of AMGN stock, worth $222,288. This represents 0.19% of its overall portfolio holdings.

Number of Shares
842
Previous 842 -0.0%
Holding current value
$222,288
Previous $263 Million 3.12%
% of portfolio
0.19%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $184,103 - $228,569
842 New
842 $226 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $192,843 - $245,030
842 New
842 $221 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mcintyre Freedman & Flynn Investment Advisers Inc Portfolio

Follow Mcintyre Freedman & Flynn Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcintyre Freedman & Flynn Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcintyre Freedman & Flynn Investment Advisers Inc with notifications on news.